Yoshimasa Aso
Department of Internal Medicine
Koshigaya Hospital
Dokkyo Medical University
Saitama
Japan
Name/email consistency: high
- Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea. Aso, Y., Ozeki, N., Terasawa, T., Naruse, R., Hara, K., Suetsugu, M., Takebayashi, K., Shibazaki, M., Haruki, K., Morita, K., Inukai, T. Transl. Res (2012)
- Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetes. Aso, Y., Takebayashi, K., Wakabayashi, S., Momobayashi, A., Sugawara, N., Terasawa, T., Naruse, R., Hara, K., Suetsugu, M., Morita, K., Inukai, T. Diabetes Res. Clin. Pract. (2010)
- Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction. Aso, Y., Suganuma, R., Wakabayashi, S., Hara, K., Nakano, T., Suetsugu, M., Matsumoto, S., Nakamachi, T., Takebayashi, K., Morita, K., Inukai, T. Transl. Res (2009)
- Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes. Aso, Y., Hara, K., Ozeki, N., Yatsuka, C., Nakano, T., Matsumoto, S., Suetsugu, M., Nakamachi, T., Takebayashi, K., Haruki, K., Inukai, T. Diabetes Res. Clin. Pract. (2009)
- Cardiovascular disease in patients with diabetic nephropathy. Aso, Y. Curr. Mol. Med. (2008)
- Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. Aso, Y. Front. Biosci. (2007)
- Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes. Aso, Y., Yamamoto, R., Suetsugu, M., Matsumoto, S., Wakabayashi, S., Matsutomo, R., Takebayashi, K., Inukai, T. Diabet. Med. (2007)
- Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Aso, Y., Yamamoto, R., Wakabayashi, S., Uchida, T., Takayanagi, K., Takebayashi, K., Okuno, T., Inoue, T., Node, K., Tobe, T., Inukai, T., Nakano, Y. Diabetes (2006)
- High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome. Aso, Y., Wakabayashi, S., Nakano, T., Yamamoto, R., Takebayashi, K., Inukai, T. Metab. Clin. Exp. (2006)
- Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor. Aso, Y., Wakabayashi, S., Yamamoto, R., Matsutomo, R., Takebayashi, K., Inukai, T. Diabetes. Care (2005)
- Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1. Aso, Y., Okumura, K.I., Yoshida, N., Tayama, K., Takemura, Y., Inukai, T. Exp. Clin. Endocrinol. Diabetes (2004)
- Results of blood inflammatory markers are associated more strongly with toe-brachial index than with ankle-brachial index in patients with type 2 diabetes. Aso, Y., Okumura, K., Inoue, T., Matsutomo, R., Yoshida, N., Wakabayashi, S., Takebayashi, K., Inukai, T. Diabetes. Care (2004)
- Dissociation between urinary pyrraline and pentosidine concentrations in diabetic patients with advanced nephropathy. Aso, Y., Takanashi, K., Sekine, K., Yoshida, N., Takebayashi, K., Yoshihara, K., Inukai, T. J. Lab. Clin. Med. (2004)
- Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia. Aso, Y., Yoshida, N., Okumura, K., Wakabayashi, S., Matsutomo, R., Takebayashi, K., Inukai, T. Clin. Chim. Acta (2004)
- Elevated pregnancy-associated plasma protein-a in sera from type 2 diabetic patients with hypercholesterolemia: associations with carotid atherosclerosis and toe-brachial index. Aso, Y., Okumura, K., Wakabayashi, S., Takebayashi, K., Taki, S., Inukai, T. J. Clin. Endocrinol. Metab. (2004)
- Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes. Aso, Y., Okumura, K., Takebayashi, K., Wakabayashi, S., Inukai, T. Diabetes. Care (2003)
- Plasma interleukin-6 is associated with coagulation in poorly controlled patients with Type 2 diabetes. Aso, Y., Okumura, K., Yoshida, N., Tayama, K., Kanda, T., Kobayashi, I., Takemura, Y., Inukai, T. Diabet. Med. (2003)
- Elevation of von Willebrand factor in plasma in diabetic patients with neuropathic foot ulceration. Aso, Y., Fujiwara, Y., Tayama, K., Inukai, T., Takemura, Y. Diabet. Med. (2002)
- Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrome in type 2 diabetes: a comparison with von Willebrand factor. Aso, Y., Fujiwara, Y., Tayama, K., Takanashi, K., Inukai, T., Takemura, Y. Exp. Clin. Endocrinol. Diabetes (2001)
- Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes. Aso, Y., Fujiwara, Y., Tayama, K., Takebayashi, K., Inukai, T., Takemura, Y. Clin. Chim. Acta (2000)
